What Is Foundayo (Orforglipron)?
So, is Foundayo simply another GLP-1 with a different name? Yes and no.

Yes, Foundayo (orforglipron) is a prescription weight loss treatment that works on the same GLP-1 pathway as Wegovy, Ozempic and Mounjaro injections. It helps regulate appetite and is taken as a once-daily tablet, offering an alternative to weekly injections.

But no, it is not simply an injectable GLP-1 squeezed into pill form. Peptide-based treatments are made from small chains of proteins, which can break down in the stomach. That is why oral options such as the Wegovy pill need an absorption enhancer called SNAC to help protect the medicine and get it through the stomach lining. It’s also why they come with specific fasting, food and drink rules.

Orforglipron works differently. It’s a small-molecule, non-peptide treatment, with around 79% of each oral dose reaching the bloodstream on average, and it doesn’t require an added absorption enhancer. In practical terms, that means it can be taken with or without food, at a time that fits your routine.

How Does Foundayo (Orforglipron) Work?
Hunger and fullness are shaped by signals travelling between your gut and your brain. GLP-1 plays an important part in that conversation.

Your body naturally releases GLP-1 after you eat, helping to regulate your appetite and signal when you have had enough. Foundayo keeps those signals active for longer, which may help you:

• Feel less hungry by reducing hunger signals in the brain
• Feel satisfied with smaller portions
• Stay fuller for longer by slowing how quickly food leaves your stomach
• Maintain steadier blood sugar levels, which may also help with appetite control

The aim is not to switch off hunger completely. Hunger signals are a normal way for your body to tell you it needs food. Foundayo may simply make those signals easier to manage, so they don’t call all the shots.

How To Use Foundayo (Orforglipron)

• Foundayo can be taken with or without food or water.
• Take 1 pill a day.
• Swallow tablets whole. Do not crush, break or chew the tablet.

How To Store Foundayo (Orforglipron)

• Store at room temperature at 20°C–25°C.
• Foundayo (Orforglipron) is sensitive to light. Protect Foundayo (Orforglipron) from light by keeping it in the original box.
• Keep Foundayo (Orforglipron) out of the reach of children.

Active ingredient: orforglipron

Other ingredients: copovidone, crospovidone, magnesium stearate, microcrystalline cellulose and sodium carbonate anhydrous.

For the most up-to-date list of ingredients, please check the Patient Information Leaflet inside the box.

Like many medications, Foundayo (Orforglipron) may cause side effects. These can include:

• Nausea
• Constipation
• Diarrhoea
• Vomiting
• Abdominal pain
• Fatigue
• Gastroesophageal reflux disease (GERD)
• Indigestion

Be sure to inform your prescriber of any concerns or side effects you experience.

Please read the following warnings carefully before use.

• Do not use Foundayo (Orforglipron) if you have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 syndrome.
• Do not use Foundayo (Orforglipron) if you’re allergic to orforglipron or any of the other ingredients in Foundayo (Orforglipron).
• In animal studies, GLP-1 medicines have been associated with thyroid tumours. It is not known if this applies to humans. Tell your healthcare professional if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.

Important: Foundayo (Orforglipron) may reduce the effectiveness of oral contraceptives. Additional barrier contraception, such as condoms, is recommended.

This treatment may not be suitable for all patients, including some older adults or those with complex health conditions.

For a full list of warnings and side effects, please see the Patient Information Leaflet.

Download patient information leaflet (PIL) on the link below:

https://www.medicines.org.uk/emc/files/pil.102527.pdf 

When is orforglipron (Foundayo) going to be available in the UK?
Foundayo has been approved for sale in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA).

Where can I buy orforglipron (Foundayo) in the UK?
Orforglipron (Foundayo) is available at regulated pharmacies.

Does orforglipron (Foundayo) cost more than Mounjaro injections?
No, Foundayo does not cost more than Mounjaro and is widely seen as a lower-cost way to lose or maintain weight.

What is the difference between orforglipron (Foundayo) and the Mounjaro injections?
Orforglipron (Foundayo) is a daily tablet that works on the GLP-1 pathway to reduce appetite, while Mounjaro is a weekly injection that targets both GLP-1 and GIP, making it more potent. Both help control hunger and support weight loss, but Mounjaro typically leads to greater results overall.

In studies, orforglipron (Foundayo) shows 11.2% average weight loss¹, compared to 22.5% with Mounjaro³,though orforglipron (Foundayo) offers the convenience of a daily pill without injections.

Is orforglipron (Foundayo) as effective as GLP-1 injections?
Orforglipron (Foundayo) is a more convenient option than GLP-1 injections, but is not as clinically effective as GLP-1 injections.

Who is eligible for orforglipron (Foundayo)?
Foundayo (Orforglipron) may be prescribed to adults:

• With a BMI of 30 or above
• With a BMI of 27 or above and a related health condition (such as high blood pressure or type 2 diabetes)

How do I switch from injections to orforglipron (Foundayo)?
If you wish to switch from weight loss injections to orforglipron (Foundayo), you need to do so under clinical supervision.

Speak to our UK-registered pharmacists about making the transition safely.

What if I miss a dose of orforglipron (Foundayo)?
If you miss a dose of orforglipron (Foundayo), take the missed dose as soon as you remember. If it’s been longer than a day, skip that dose and take the next day’s dose as normal.

Is orforglipron (Foundayo) effective for weight loss in non-diabetics?
Yes, Foundayo (Orforglipron) is effective for weight loss in non-diabetics. The ATTAIN-1 clinical trial demonstrated that orforglipron (Foundayo) produced an average weight loss of 12.4% in non-diabetics.

What happens if you take too much orforglipron (Foundayo)?
If you take more orforglipron (Foundayo) than you’ve been prescribed, you should seek medical advice as soon as possible.

If you experience severe symptoms, seek medical advice immediately.

What should I avoid while using orforglipron (Foundayo)?
Avoid eating greasy, rich or high-fat food when using orforglipron (Foundayo). It works best with a healthy balanced diet and increased physical activity.

Orforglipron key takeaways
Orforglipron (Foundayo) is a weight loss treatment that offers a convenient alternative to injections. As a once-daily tablet with no food or timing restrictions, it may suit people looking for a simpler way to manage their weight alongside a healthy diet and lifestyle.

It requires a prescription and clinical assessment to ensure it’s safe and suitable for you.

If you’re exploring weight loss treatment options, you can start an online consultation with our UK-registered clinicians. They’ll assess your needs and help you choose the most appropriate treatment for you.